Lipid-lowering medications and risk of malignant melanoma: a Mendelian randomization study.

MLA

BoWen Yang, et al. “Lipid-Lowering Medications and Risk of Malignant Melanoma: A Mendelian Randomization Study.” Frontiers in Oncology, July 2024, pp. 1–7. EBSCOhost, https://doi.org/10.3389/fonc.2024.1408972.

APA

BoWen Yang, HanYu Wang, WenYuan Song, JiuHuan Feng, & ShuFang Hou. (2024). Lipid-lowering medications and risk of malignant melanoma: a Mendelian randomization study. Frontiers in Oncology, 1–7. https://doi.org/10.3389/fonc.2024.1408972

Chicago

BoWen Yang, HanYu Wang, WenYuan Song, JiuHuan Feng, and ShuFang Hou. 2024. “Lipid-Lowering Medications and Risk of Malignant Melanoma: A Mendelian Randomization Study.” Frontiers in Oncology, July, 1–7. doi:10.3389/fonc.2024.1408972.